OneBio® – Leveraging Next Gen Technology to Speed the Path to Clinic
Information
Speed to first-in-human studies can be challenging for biologics due to their complex nature. Catalent Biologics’ OneBio integrated solution leverages next generation technology, including GPEx® Lightning cell line development, and integrated program management to shorten the timeline to bring biologic therapies to patients.
Learn about Catalent’s streamlined approach and latest investments to support pre-clinical to early-stage programs across drug substance, drug product, analytical and clinical supply logistics.
